Labelling update regarding the use of non-steroidal anti-inflammatory drugs (NSAIDs) beyond 20 weeks of pregnancy and risk of kidney damage to unborn babies

June 9th, 2021
©2021 Newfoundland & Labrador Pharmacy Board